Jen-Yao Chang

Jen-Yao Chang

Auto-generated profile, based on publicly available information

Jen-Yao Chang

Chemical Genomics Centre of the Max Planck Society, Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Chemistry – A European Journal
Verified
Journal Article
Open access
JOJoseph Openy
Joseph Openy
GAGulshan Amrahova
Gulshan Amrahova
JCJen‐Yao Chang
Jen‐Yao Chang
ANAnaïs Noisier
Anaïs Noisier
PHPeter ‘t Hart
Peter ‘t Hart
Introduction of unnatural amino acids can significantly improve the binding affinity and stability of peptides. Commercial availability of such amino acids is limited, and their synthesis is a long and tedious process. We here describe a method that allows the functionalization of peptides directly on solid‐support by converting lysine residues to Katritzky salts, and subjecting them to a photochemical Giese reaction under mild reaction conditions. The method avoids the need for amino acid synthesis and instead offers a late‐stage modification route for rapid peptide diversification. While numerous modification approaches at the lysine amine have been described, this work provides the first example of deaminative functionalization of peptides at lysine. The two‐step protocol is compatible with various substrates, lysine analogues, resins, and all proteinogenic amino acids. Finally, by leveraging solid‐phase modification, this protocol facilitates the functionalization of longer peptides as was demonstrated using biologically relevant peptides of up to 15 amino acids.

13 July 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
SSStefan Schmeing
Stefan Schmeing
GAGulshan Amrahova
Gulshan Amrahova
KBKatrin Bigler
Katrin Bigler
JCJen-Yao Chang
Jen-Yao Chang
JOJoseph Openy
Joseph Openy
PHPeter 'T Hart
Peter 'T Hart
The diverse role of the splicing factor PTBP1 in human cells has been widely studied and was found to be a driver for several diseases. PTBP1 binds RNA through its RNA-recognition motifs which lack obvious pockets for inhibition. A unique transient helix has been described to be part of its first RNA-recognition motif and to be important for RNA binding. In this study, we further confirmed the role of this helix and envisioned its dynamic nature as a unique opportunity to develop stapled peptide inhibitors of PTBP1. The peptides were found to be able to inhibit RNA binding via fluorescence polarization assays and directly occupy the helix binding site as observed by protein crystallography. These cell-permeable inhibitors were validated in cellulo to alter the regulation of alternative splicing events regulated by PTBP1. Our study demonstrates transient secondary structures of a protein can be mimicked by stapled peptides to inhibit allosteric mechanisms.

10 January 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
JCJen-Yao Chang
Jen-Yao Chang
CNCora Neugebauer
Cora Neugebauer
AKAnne Mues Genannt Koers
Anne Mues Genannt Koers
PHPeter 'T Hart
Peter 'T Hart
WD repeat domain 5 (WDR5) plays an important role as a scaffold protein in both protein–protein and RNA–protein complexes involved in epigenetic gene regulation. In particular, some of these lncRNAs were reported to regulate the expression of genes in cis as well as themselves through binding WDR5. In this report, we investigate the two known binding sites of WDR5 in relation to lncRNA binding and expression. The WBM binding site mediates both protein–protein and lncRNA–protein interactions while the WIN site, which is on the opposite side of the protein, is only known to mediate protein–protein interactions. To dissect the function of different binding sites on WDR5, we characterized them with selective peptide ligands using fluorescence polarization and used these to demonstrate the selectivity of small molecule inhibitors of these two major binding sites. RNA immunoprecipitation experiments were performed to show that lncRNA–WDR5 complex formation could be interrupted using a WBM site inhibitor. Finally, we demonstrated that WDR5 regulated lncRNAs are down regulated with different sensitivity toward the corresponding inhibitors, demonstrating the potential of targeting lncRNA–protein interactions to reduce oncogenic lncRNA expression.

8 August 2023 in Chemical Communications
Verified
Journal Article
Open access
PDF file
JCJen-Yao Chang
Jen-Yao Chang
CNCora Neugebauer
Cora Neugebauer
SSStefan Schmeing
Stefan Schmeing
GAGulshan Amrahova
Gulshan Amrahova
PHPeter ‘t Hart
Peter ‘t Hart
An optimized protein–protein interaction mimetic inhibits long non-coding RNA binding by WDR5.

1 December 2015 in Journal of Structural Chemistry
Verified
Journal Article
Closed access
PDF file
JTJianbo Tong
Jianbo Tong
JCJ. Chang
J. Chang
LLL. Li
L. Li
MBM. Bai
M. Bai
By applying a three-dimensional holographic vector of the atomic interaction field (3D-HoVAIF) to express the structure of three classical peptide drugs, quantitative structure activity relationship...